TY  - JOUR

T1  - Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial

JO  - EBioMedicine

UR  - http://eprints.whiterose.ac.uk/163773/

PY  - 2020/07/07

AU  - Camu W

AU  - Mickunas M

AU  - Veyrune J-L

AU  - Payan C

AU  - Garlanda C

AU  - Locati M

AU  - Juntas-Morales R

AU  - Pageot N

AU  - Malaspina A

AU  - Andreasson U

AU  - Kirby J et al

ED  - 

DO  - DOI: 10.1016/j.ebiom.2020.102844

PB  - Elsevier BV

Y2  - 2024/10/23

ER  -